Cargando…

Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study

OBJECTIVE: To explore which attributes of insulin therapy drive patients’ preferences for management in Canada and Brazil. METHODS: A qualitative design was implemented in which a total of 32 patients with type 2 diabetes from Canada and Brazil, were interviewed in one of the 4 focus groups, or 16 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Guimarães, Camila, Marra, Carlo A, Gill, Sabrina, Meneilly, Graydon, Simpson, Scot, Godoy, Ana LPC, Foss de, Maria Cristina, Freitas, Queiroz, Regina HC, Lynd, Larry
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915552/
https://www.ncbi.nlm.nih.gov/pubmed/20694179
_version_ 1782184936626716672
author Guimarães, Camila
Marra, Carlo A
Gill, Sabrina
Meneilly, Graydon
Simpson, Scot
Godoy, Ana LPC
Foss de, Maria Cristina
Freitas,
Queiroz, Regina HC
Lynd, Larry
author_facet Guimarães, Camila
Marra, Carlo A
Gill, Sabrina
Meneilly, Graydon
Simpson, Scot
Godoy, Ana LPC
Foss de, Maria Cristina
Freitas,
Queiroz, Regina HC
Lynd, Larry
author_sort Guimarães, Camila
collection PubMed
description OBJECTIVE: To explore which attributes of insulin therapy drive patients’ preferences for management in Canada and Brazil. METHODS: A qualitative design was implemented in which a total of 32 patients with type 2 diabetes from Canada and Brazil, were interviewed in one of the 4 focus groups, or 16 individual interviews. Eighteen participants (56%) were women and fourteen participants (44%) were men (15 insulin nonusers and 17 insulin users). Two focus groups of 4 participants each and 9 individual interviews were conducted in Brazil. In Canada, 2 focus groups of 4 participants each and 7 individual interviews were conducted. A framework analysis was used to analyse all data. RESULTS: Brazilian participants, when considering two insulin treatments, would prefer the one that had fewer side-effects (specially hypoglycemia events), was noninjectable, had the lowest cost and was most effective. Meanwhile, Canadian participants would prefer a treatment that had fewer side-effects (specially weight gain), was less invasive, was more convenient and was most effective. CONCLUSIONS: Finding the insulin-delivery system and the attributes of insulin therapy that best meet patients’ preferences may lead to improved control, through improved compliance, which may ultimately reduce the financial burden of the disease and improve quality of life.
format Text
id pubmed-2915552
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-29155522010-08-06 Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study Guimarães, Camila Marra, Carlo A Gill, Sabrina Meneilly, Graydon Simpson, Scot Godoy, Ana LPC Foss de, Maria Cristina Freitas, Queiroz, Regina HC Lynd, Larry Patient Prefer Adherence Original Research OBJECTIVE: To explore which attributes of insulin therapy drive patients’ preferences for management in Canada and Brazil. METHODS: A qualitative design was implemented in which a total of 32 patients with type 2 diabetes from Canada and Brazil, were interviewed in one of the 4 focus groups, or 16 individual interviews. Eighteen participants (56%) were women and fourteen participants (44%) were men (15 insulin nonusers and 17 insulin users). Two focus groups of 4 participants each and 9 individual interviews were conducted in Brazil. In Canada, 2 focus groups of 4 participants each and 7 individual interviews were conducted. A framework analysis was used to analyse all data. RESULTS: Brazilian participants, when considering two insulin treatments, would prefer the one that had fewer side-effects (specially hypoglycemia events), was noninjectable, had the lowest cost and was most effective. Meanwhile, Canadian participants would prefer a treatment that had fewer side-effects (specially weight gain), was less invasive, was more convenient and was most effective. CONCLUSIONS: Finding the insulin-delivery system and the attributes of insulin therapy that best meet patients’ preferences may lead to improved control, through improved compliance, which may ultimately reduce the financial burden of the disease and improve quality of life. Dove Medical Press 2010-07-21 /pmc/articles/PMC2915552/ /pubmed/20694179 Text en © 2010 Guimarães et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Guimarães, Camila
Marra, Carlo A
Gill, Sabrina
Meneilly, Graydon
Simpson, Scot
Godoy, Ana LPC
Foss de, Maria Cristina
Freitas,
Queiroz, Regina HC
Lynd, Larry
Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study
title Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study
title_full Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study
title_fullStr Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study
title_full_unstemmed Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study
title_short Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study
title_sort exploring patients’ perceptions for insulin therapy in type 2 diabetes: a brazilian and canadian qualitative study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915552/
https://www.ncbi.nlm.nih.gov/pubmed/20694179
work_keys_str_mv AT guimaraescamila exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT marracarloa exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT gillsabrina exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT meneillygraydon exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT simpsonscot exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT godoyanalpc exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT fossdemariacristina exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT freitas exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT queirozreginahc exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy
AT lyndlarry exploringpatientsperceptionsforinsulintherapyintype2diabetesabrazilianandcanadianqualitativestudy